Brister Mark
Insider CIK 1323223 · OBLN VP of Research and Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2020-01-24 | 2020-01-28 | 110,281 | — | $0 | 110,281 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2019-10-25 | 2019-10-28 | 13,000 | — | $0 | 13,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy deriv | 2019-08-06 | 2019-08-08 | 3,750 | — | $0 | 3,750 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2019-08-06 | 2019-08-08 | 5,000 | $4.00 | $20.0K | 38,865 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2019-07-23 | 2019-07-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2019-01-02 | 2019-01-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2018-08-23 | 2018-08-27 | 107,142 | $1.82 | $195.0K | 338,634 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2018-04-30 | 2018-05-02 | 2,622 | $3.27 | $8.6K | 166,492 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2018-01-02 | 2018-01-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2017-10-31 | 2017-11-02 | 1,860 | $7.17 | $13.3K | 163,870 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2017-04-30 | 2017-05-02 | 1,550 | $9.03 | $14.0K | 162,010 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2016-11-09 | 2016-11-14 | 90,000 | — | $0 | 90,000 | SEC↗ |